Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACH: Eltanexor in Advanced Solid Tumors
NCT05010525Phase 2Terminated
- Sponsor
- Antengene
- Start
- Sep 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltanexor in solid tumor (advanced stage), penile squamous cell carcinoma (PSCC), nasopharyngeal carcinoma (NPC), sponsored by Antengene. Started Sep 2021; status: terminated.
02
Drugs
eltanexor
03
Conditions
solid tumor (advanced stage)penile squamous cell carcinoma (PSCC)nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT05010525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05010525.